latest news releases from the newsroom
Buy.com Lowers Prices to 15% Off Amazon.com's Book Prices for Three Days Only
ALISO VIEJO, Calif., July 8, 2003 (PRIMEZONE) -- Buy.com, Inc., The Internet Superstore(tm), today announced it will lower its book prices to 15% below Amazon.com's book prices for a special three-day period. From July 11-13, Buy.com customers can shop online and receive books at 15% off Amazon.com's price. This offer marks the one-year anniversary of Buy.com's "10% below Amazon.com's book prices" campaign, which was wildly successful and is still in place today.
Kingdom Ventures Inc.
Kingdom Ventures Projects Revenue Increase of over 150% in Q2 of 2003 -- Corporate Activity Structure also Announced
MINDEN, Nevada, July 8, 2003 (PRIMEZONE) -- Kingdom Ventures, Inc. (OTCBB:KDMV), a rapidly growing church development company, reported today expected growth in revenues in its 2nd Quarter year 2003 ending July 31, 2003. Revenues projected to increase to $2,100,000 in Q2-2003 from $828,248 in Q2 of 2002 according to Gene Jackson, CEO/President.
Song Networks Holding
Song Networks Signs Agreement with Ahlsell
STOCKHOLM, Sweden, July 8, 2003 (PRIMEZONE) -- Song Networks Holding AB's (Stockholmsborsen:SONW) (Other OTC:SONWF) Swedish subsidiary Song Networks Svenska AB has signed an agreement with Ahlsell for the supply of data communication in Sweden and Norway. Together with previous agreement Ahlsell connects in total 125 units in the Nordic region to their IP based VPN solution. The new agreement extends over two years.
Gambro Receives US 510(k) Approval for new Dialyzer for Treatment of Renal Failure
STOCKHOLM, Sweden, July 8, 2003 (PRIMEZONE) -- Gambro (Other OTC:GAMOF) (Other OTC:GAMBF) (Stockholmsborsen: GAMBaST, GAMBbST), a leading international medical technology and healthcare company, today announced that Gambro Renal Products in the United States has received FDA clearance of the 510(k) Notification for the Polyflux(R) LR Hemodialyzer. This is the newest member of its Polyflux hemodialyzer product line, used for the treatment of chronic and acute renal failure. The Polyflux LR may be reprocessed for reuse on the same patient.